“Baricitinib Achieved Complete Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials”. 2025. SKIN The Journal of Cutaneous Medicine 9 (1): s520. https://doi.org/10.25251/skin.9.supp.520.